Architectural Heterogeneity in Tumors Caused by Differentiation
Alters Intratumoral Drug Distribution and Affects Therapeutic Synergy of Antiangiogenic Organoselenium Compound
Figure 2
Effect of MSC on tumor growth ((a), (c)) and tumor volume ((b), (d)) at the end of 14 days treatment.
